Connect with us
European Gaming Congress 2024

Blockchain Press Releases

Flow Cytometry Market worth $7.0 billion | MarketsandMarkets

Published

on

flow-cytometry-market-worth-$7.0-billion-|-marketsandmarkets

CHICAGO, Aug. 9, 2023 /PRNewswire/ — In the near future, the flow cytometry industry is poised to undergo remarkable advancements, driven by ongoing innovations in technology and its widening applications across various fields. With the integration of artificial intelligence and machine learning, data analysis and interpretation will become more efficient and accurate, enabling researchers and clinicians to gain deeper insights from complex cellular data. The miniaturization of flow cytometry instruments will lead to portable and point-of-care devices, revolutionizing diagnostics and personalized medicine. Additionally, the incorporation of multi-parameter analysis and higher-throughput capabilities will enhance the speed and comprehensiveness of cellular profiling. As the industry continues to evolve, collaborations between academia, industry, and healthcare will play a pivotal role in shaping the future of flow cytometry, unlocking its potential to uncover novel discoveries and improve patient outcomes.

Flow Cytometry Market in terms of revenue was estimated to be worth $4.7 billion in 2023 and is poised to reach $7.0 billion by 2028, growing at a CAGR of 8.3% from 2023 to 2028 according to a new report by MarketsandMarkets™.

The growth of this market is driven by the increasing prevalence of chronic diseases and increasing funding for research. Moreover, the launch of novel products in the market by key market players and increased use of flow cytometry in clinical research & diagnostics, such as HIV/AIDS Monitoring, organ transplantation, and cancer diagnostics, are some of the elements propelling the growth of the market.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65374584

Browse in-depth TOC on “Flow Cytometry Market”

Advertisement
Stake.com

477 – Tables
47 – Figures
416 – Pages

Flow Cytometry Market Scope:

Report Coverage

Details

Market Revenue in 2023

Advertisement
Stake.com

$4.7 billion

Estimated Value by 2028

$7.0 billion

Growth Rate

Poised to grow at a CAGR of 8.3%

Advertisement
Stake.com

Market Size Available for

2021–2028

Forecast Period

2023–2028

Forecast Units

Advertisement
Stake.com

Value (USD Billion)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Segments Covered

Technology, Product & Service, Application & End User

Advertisement
Stake.com

Geographies Covered

North America, Europe, Asia Pacific, Latin America (LATAM), and Middle East and Africa (MEA)

Report Highlights

Updated financial information / product portfolio of players

Key Market Opportunities

Advertisement
Stake.com

Public-private funding initiatives in stem cell research

Key Market Drivers

Technological advancements in flow cytometry instruments

 

The Reagents & consumables segment accounted for the largest share of the product & service segment in the flow cytometry market in 2022.

Advertisement
Stake.com

Based on products & services, the flow cytometry market is segmented into software, services, reagents & consumables, instruments, and accessories. Reagents & consumables accounted for the largest share of the flow cytometry market in 2022. The factors attributable to the growth, development of high-quality reagents, increased research activities, and launch of application-specific cytometry reagents.

The Research application segment accounted for the largest share of the application segment in the flow cytometry market in 2022.

Based on applications, the flow cytometry market is segmented into clinical, research and industrial applications.  In 2022, the research applications segment accounted for the dominant share in the global flow cytometry market. The dominance of the market is attributable to various factors, such as increased research activities & funding and a rise in industrial & academic collaboration. The clinical applications segment is likely to grow at a significant CAGR owing to the increased adoption of flow cytometry in clinical applications.

North America dominated the flow cytometry market in 2022.

Based on region, the flow cytometry market is segmented into North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa. In 2022, North America dominated the market, followed by Europe. The presence of key market players in the region and increasing public-private initiatives for research activities are key factors supporting the growth of the North American flow cytometry market. The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. The high prevalence of HIV/AIDS & cancer and rising treatment options for target diseases (cancer and immunological disorders) are driving the market growth. Further factors like rising government funding and the strong presence of key players in the region are some of the factors anticipated to contribute to the flow cytometry market growth in the Asia Pacific.

Advertisement
Stake.com

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=65374584

Flow Cytometry Market Dynamics:

Drivers:

  1. Rising incidence of HIV/AIDS and cancer
  2. Wide applications in research for drug discovery & development
  3. Use of flow cytometry in regenerative medicine
  4. Growing public-private initiatives in immunology and immuno-oncology research
  5. Technological advancements in flow cytometry instruments

Restraints:

  1. High product pricing

Opportunities:

  1. High growth potential in emerging economies
  2. Rising focus on stem cell research
  3. Uptake of recombinant DNA technology for antibody production

Challenges:

  1. Complexities related to reagent development
  2. Shortage of skilled professionals

Key Market Players:

Key players in the flow cytometry market include BD (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Sony Corporation (Japan), Bio-Rad Laboratories, Inc. (US), Miltenyi Biotec (Germany), Enzo Biochem, Inc. (US), Sysmex Corporation (Japan), bioMérieux (France), Cytonome/ST, LLC (US), Sartorius AG (Germany), Cytek Biosciences (US), Union Biometrica, Inc. (US), Luminex Corporation (Italy),  Apogee Flow Systems Ltd. (UK), Stratedigm, Inc. (US), NanoCellect Biomedical, Inc. (US), On-chip Biotechnologies, Co., Ltd. (Japan), (US), Nexcelom Biosciences LLC. (US), BennuBio Inc. (US), Orflo Technologies (US), Bay Biosciences Co., Ltd. (Japan), BioLegend, Inc. (US), and CytoBuoy B.V (Netherlands).

Recent Developments:

Advertisement
Stake.com
  • In June 2023, BD launched The BD FACSDuet Premium Sample Preparation System to automate sample preparation in clinical flow cytometry diagnostics.
  • In May 2023, Sysmex launched Clinical Flow Cytometry System Flow Cytometer XF-1600, Sample Preparation System PS-10, antibody reagents, and other related products in Japan.
  • In June 2022, BD (US) launched BD FACSDiscover S8 Cell Sorter with high-speed imaging technology that sorts cells based on visual characteristics.
  • In March 2022, Beckman Coulter, Inc. (US) launched a fully automated sample preparation system (SPS) CellMek SPS, which offers on-demand processing for many sample types to help laboratories expand their capabilities.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=65374584

Flow Cytometry Market Advantages:

  • Multiparameter Analysis: Flow cytometry enables simultaneous analysis of multiple cellular parameters (e.g., size, shape, markers), offering a comprehensive view of complex cell populations and their interactions.
  • Single-Cell Resolution: The technology provides insights into individual cells, allowing researchers to study heterogeneity, identify rare cell populations, and understand cellular behavior at a granular level.
  • High Throughput: Flow cytometers can analyze thousands of cells per second, facilitating rapid data acquisition and significantly reducing experiment duration.
  • Automation and Reproducibility: Integration of automation and robotics ensures consistent and reproducible results, minimizing experimental variations and human errors.
  • Cell Sorting: Flow cytometers equipped with cell sorting capabilities enable isolation of specific cell subsets for downstream analysis, transplantation, or further experimentation.
  • Functional Analysis: Flow cytometry can assess cellular functions, such as viability, proliferation, apoptosis, and cell cycle progression, providing insights into cell health and behavior.
  • Immunophenotyping: Valuable in immunology research, flow cytometry helps characterize immune cell populations, aiding in the understanding of immune responses, diseases, and therapies.
  • Drug Discovery: Flow cytometry plays a pivotal role in drug development by assessing drug effects on cells, identifying potential drug candidates, and evaluating drug toxicity.
  • Cancer Research: It aids in cancer diagnostics and research by detecting cancer cells, characterizing tumor heterogeneity, and evaluating treatment responses.
  • Personalized Medicine: Flow cytometry contributes to personalized medicine by enabling tailored treatments based on individual patient profiles and disease characteristics.
  • Advanced Data Analysis: Integration with AI and machine learning enhances data interpretation, uncovering complex patterns and relationships within datasets.
  • Portable Systems: Miniaturization of instruments results in portable flow cytometry devices suitable for point-of-care diagnostics, field research, and resource-limited settings.
  • Clinical Applications: It’s used in clinical laboratories for diagnosing immunological disorders, monitoring disease progression, and assessing treatment efficacy.
  • Research Versatility: Flow cytometry finds applications in various fields, including immunology, hematology, microbiology, neuroscience, stem cell research, and more.
  • Collaborative Potential: The technology encourages collaboration between researchers, clinicians, and industries, fostering cross-disciplinary advancements.

These pointers highlight the multifaceted advantages of flow cytometry, making it an indispensable tool in scientific research, clinical diagnostics, and healthcare innovation.

Related Reports:

Cell Analysis Market – Global Forecasts to 2028

Single Cell Analysis Market – Global Forecasts to 2028

Stem Cell Assay Market – Global Forecasts to 2027

Advertisement
Stake.com

Esoteric Testing Market – Global Forecasts to 2026

Sepsis Diagnostics Market – Global Forecasts to 2026

About MarketsandMarkets™:

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Advertisement
Stake.com

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/flow-cytometry-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/flow-cytometry.asp

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/flow-cytometry-market-worth-7-0-billion–marketsandmarkets-301896791.html

Advertisement
Stake.com
Continue Reading

Blockchain

Ethereum ETFs Aren’t Blockchain But Is A Revolutionary Tech: Top 6 Amazing Reasons To Invest In Them

Published

on

ethereum-etfs-aren’t-blockchain-but-is-a-revolutionary-tech:-top-6-amazing-reasons-to-invest-in-them

The financial landscape is rapidly evolving, with the integration of blockchain technology and cryptocurrencies becoming more prominent. Among these, Ethereum ETFs (Exchange-Traded Funds) have emerged as a significant investment vehicle, offering exposure to the Ethereum blockchain’s native cryptocurrency, Ether (ETH), without requiring direct ownership. However, it’s crucial to understand that Ethereum ETFs are distinct from the blockchain itself and serve different purposes in the investment world.

Understanding Ethereum and ETFs

Ethereum: A decentralized platform that enables the creation and execution of smart contracts and decentralized applications (dApps). It operates using its cryptocurrency, Ether (ETH), which fuels the network.

ETF (Exchange-Traded Fund): A type of investment fund that holds a collection of assets and is traded on stock exchanges. ETFs can include various asset classes, such as stocks, commodities, or bonds.

Advertisement
Stake.com

Ethereum ETFs: The Intersection of Traditional Finance and Cryptocurrency

An Ethereum ETF provides a way for investors to gain exposure to the price movements of Ether without directly purchasing the cryptocurrency. This is achieved through an ETF structure, where the fund holds assets linked to the value of Ether, and investors can buy shares of the ETF on traditional stock exchanges.

Key Features of Ethereum ETFs:

  1. Indirect Exposure: Investors gain exposure to Ether’s price changes without needing to manage or store the cryptocurrency themselves.
  2. Regulatory Compliance: Unlike the relatively unregulated cryptocurrency market, ETFs operate under the oversight of financial regulators, offering a layer of investor protection.
  3. Accessibility: Ethereum ETFs are available through traditional brokerage platforms, making them accessible to a broader range of investors.

Why Invest in an Ethereum ETF?

  1. Diversification: Including an Ethereum ETF in a portfolio can provide exposure to the cryptocurrency market, potentially enhancing diversification beyond traditional assets.
  2. Convenience and Familiarity: ETFs are a familiar investment product, simplifying the process of investing in cryptocurrencies.
  3. Professional Management: ETF managers handle the investment decisions, including the buying and selling of assets, which can be advantageous for those less familiar with the cryptocurrency space.
  4. Regulatory Oversight: ETFs are subject to regulatory scrutiny, potentially offering more safety and transparency compared to direct cryptocurrency investments.
  5. Potential for Growth: As the cryptocurrency market grows, ETFs linked to assets like Ether may benefit from rising prices.

Key Differences Between Ethereum and Ethereum ETFs

While both are related to the Ethereum blockchain, Ethereum itself and Ethereum ETFs represent different forms of investment:

  • Ethereum (ETH):
    • Direct ownership of the cryptocurrency.
    • Full exposure to Ethereum’s features, including staking and network participation.
    • Traded on cryptocurrency exchanges.
    • Highly volatile and largely unregulated.
  • Ethereum ETF:
    • Indirect exposure through shares representing Ether’s value.
    • Traded on traditional stock exchanges under regulatory oversight.
    • Offers a more stable and familiar investment structure.
    • Typically lower volatility compared to direct cryptocurrency ownership.

Future Considerations for Ethereum ETFs

The approval and launch of Ethereum ETFs mark a significant milestone in bringing cryptocurrencies closer to mainstream finance. They offer a convenient and regulated means for investors to gain exposure to the growing digital assets market. However, they also come with limitations, such as not allowing direct participation in the Ethereum ecosystem’s innovations, like dApps and smart contracts.

Advertisement
Stake.com

As the market evolves, we may see more sophisticated financial products that better capture the full potential of the Ethereum ecosystem. For now, Ethereum ETFs provide a balanced option for those interested in cryptocurrency exposure within the framework of traditional finance.

In conclusion, while Ethereum ETFs offer a gateway into the world of digital assets, they should be viewed as complementary to, rather than a replacement for, direct investment in the underlying blockchain technologies. Investors should carefully consider their investment goals, risk tolerance, and the unique attributes of both Ethereum and Ethereum ETFs when making investment decisions.

Source: blockchainmagazine.net

The post Ethereum ETFs Aren’t Blockchain But Is A Revolutionary Tech: Top 6 Amazing Reasons To Invest In Them appeared first on HIPTHER Alerts.

Advertisement
Stake.com
Continue Reading

Blockchain

Nexo Reaffirms Commitment to Data Protection with SOC 3 and SOC 2 Compliance

Published

on

nexo-reaffirms-commitment-to-data-protection-with-soc-3-and-soc-2-compliance

Nexo, a leading institution in the digital assets industry, has reinforced its commitment to data security by renewing its SOC 2 Type 2 audit and attaining a new SOC 3 Type 2 assessment without any exceptions. This rigorous audit process, conducted by A-LIGN, a respected independent auditor specializing in security compliance, confirms Nexo’s adherence to stringent Trust Service Criteria for Security and Confidentiality.

Key Achievements and Certifications

  1. SOC 2 and SOC 3 Compliance:
    • SOC 2 Type 2: This audit evaluates and reports on the effectiveness of an organization’s controls over data security, particularly focusing on the confidentiality, integrity, and availability of systems and data.
    • SOC 3 Type 2: This public-facing report provides a summary of SOC 2 findings, offering assurance to customers and stakeholders about the robustness of Nexo’s data security practices.
  2. Additional Trust Service Criteria:
    • Nexo expanded the scope of these audits to include Confidentiality, showcasing a deep commitment to protecting user data.
  3. Security Certifications:
    • The company also adheres to the CCSS Level 3 Cryptocurrency Security Standard, and holds ISO 27001, ISO 27017, and ISO 27018 certifications, awarded by RINA. These certifications are benchmarks for security management and data privacy.
  4. CSA STAR Level 1 Certification:
    • This certification demonstrates Nexo’s adherence to best practices in cloud security, further solidifying its position as a trusted partner in the digital assets sector.

Impact on Customers and Industry Standards

Nexo’s rigorous approach to data protection and compliance sets a high standard in the digital assets industry. By achieving these certifications, Nexo provides its over 7 million users across more than 200 jurisdictions with confidence in the security of their data. These achievements not only emphasize the company’s dedication to maintaining top-tier security standards but also highlight its proactive stance in fostering trust and transparency in digital asset management.

Nexo’s Broader Mission

Advertisement
Stake.com

As a premier institution for digital assets, Nexo offers a comprehensive suite of services, including advanced trading solutions, liquidity aggregation, and tax-efficient credit lines backed by digital assets. Since its inception, the company has processed over $130 billion, showcasing its significant impact and reliability in the global market.

In summary, Nexo’s successful completion of SOC 2 and SOC 3 audits, along with its comprehensive suite of certifications, underscores its commitment to the highest standards of data security and operational integrity. This dedication positions Nexo as a leader in the digital assets space, offering unparalleled security and peace of mind to its users.

Source: blockchainreporter.net

The post Nexo Reaffirms Commitment to Data Protection with SOC 3 and SOC 2 Compliance appeared first on HIPTHER Alerts.

Advertisement
Stake.com
Continue Reading

Blockchain

Marshall Becomes First US Senator to Walk from Controversial Crypto Bill He Co-Sponsored

Published

on

marshall-becomes-first-us-senator-to-walk-from-controversial-crypto-bill-he-co-sponsored

Republican Senator Roger Marshall has withdrawn his support for the Digital Asset Anti-Money Laundering Act of 2023, a controversial bill he initially co-sponsored with Senator Elizabeth Warren and others. This bill, reintroduced in the Senate on July 27, 2023, aimed to bring the cryptocurrency industry into alignment with existing anti-money laundering (AML) and counter-terrorism financing (CTF) laws.

Key Provisions of the Bill

The legislation proposed stringent regulations on digital asset providers, including unhosted wallet providers, miners, and validators, by classifying them as financial institutions under the Bank Secrecy Act (BSA). It mandated these entities to adhere to BSA compliance requirements, which include extensive reporting and monitoring responsibilities. Additionally, the bill called for the Financial Crimes Enforcement Network (FinCEN) to establish regulations for reporting significant foreign digital asset holdings and to create compliance measures to address risks associated with anonymity-enhancing technologies.

Senator Marshall’s Shift

Advertisement
Stake.com

Marshall’s withdrawal from the bill comes as a surprise, particularly given his earlier criticisms of cryptocurrencies, which he has described as a “threat to national security.” This includes concerns over stablecoins like Tether potentially facilitating illegal activities and circumventing U.S. sanctions. Despite his earlier stance, Marshall’s departure from the legislation suggests a reconsideration of the bill’s implications or an alignment with broader political and industry perspectives on cryptocurrency regulation. His office has not provided a comment on the reasons for his withdrawal.

Political and Industry Reactions

The bill had garnered significant bipartisan support, with 18 co-sponsors, reflecting a broader concern in Congress over regulating the rapidly growing cryptocurrency market. However, it has also faced criticism for potentially imposing impractical compliance burdens that could stifle innovation and push crypto activities offshore. Critics argue that the bill’s stringent requirements could inadvertently drive users toward unregulated platforms, thereby undermining its intent to enhance security and regulatory oversight.

Broader Context

The withdrawal comes at a time when cryptocurrency regulation is a highly contentious issue in U.S. politics. Former President Donald Trump has promised to relax crypto regulations if elected, contrasting with the current administration’s more stringent stance. Under President Joe Biden, the Securities and Exchange Commission (SEC) and other regulatory bodies, led by figures like Gary Gensler, have taken a more rigorous approach to regulating the sector, which has drawn criticism for being overly restrictive.

Advertisement
Stake.com

Senator Marshall’s decision to step back from the Digital Asset Anti-Money Laundering Act reflects the complex and evolving nature of cryptocurrency regulation in the U.S. While the bill seeks to bring greater oversight and security to the crypto industry, it also raises concerns about regulatory overreach and its potential negative impact on innovation and privacy. As the debate continues, the U.S. legislative and regulatory landscape for cryptocurrencies remains in flux, balancing the need for security with the desire to foster technological innovation.

Source: decrypt.co

The post Marshall Becomes First US Senator to Walk from Controversial Crypto Bill He Co-Sponsored appeared first on HIPTHER Alerts.

Continue Reading
Advertisement
Stake.com
Advertisement

Latest News

Recent Listings

  • Global Payout, Inc.

    Since the Company’s inception in 2009, Global Payout, Inc. has been a leading provider of compreh...

  • MTrac Tech Corp.

    MTrac Tech Corporation, a Nevada Corporation, is a privately held, wholly owned subsidiary of Glo...

  • Net1

    Net1 is a leading provider of transaction processing services, financial inclusion products ...

  • uBUCK Technologies SEZC

    Based in Georgetown, Cayman Islands, uBUCK Tech is a fintech enterprise that specializes in digit...

  • LiteLink Technologies Inc.

      LiteLink is a major player in developing world-class enterprise platforms that utilize ar...

  • Good Gamer Corp.

      Good Gamer Corp. is a privately-held technology company focusing on gamers and streamers....

  • BitPay

      Founded in 2011, BitPay pioneered blockchain payment processing with the mission of trans...

  • About Net1

      Net1 is a leading provider of transaction processing services, financial inclusion produc...

  • Blockchain Foundry Inc.

    Headquartered in Toronto, Canada, Blockchain Foundry (CSE:BCFN)(FWB:8BF)(OTC:BLFDF) is a global b...

  • Sixgill

    Sixgill provides a full suite of universal data automation and authenticity products and services...

Trending on TBE